Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease

Clinical and Vaccine Immunology

Volumn 18, Issue 5, 2011, Pages 749-757

  Trible, Benjamin R ^a   Kerrigan, Maureen ^a   Crossland, Nicholas ^a   Potter, Megan ^a   Faaberg, Kay ^b   Hesse, Richard ^a   Rowland, Raymond R R ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CAPSID PROTEIN; EPITOPE; OLIGOPEPTIDE; POLYPEPTIDE; PORCINE CIRCOVIRUS TYPE 2 VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; CONTROLLED STUDY; IMMUNOREACTIVITY; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PORCINE CIRCOVIRUS TYPE 2; PORCINE DERMATITIS AND NEPHROPATHY SYNDROME; POSTWEANING MULTISYSTEMIC WASTING SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY; SWINE; VACCINATION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; DNA, VIRAL; EPITOPE MAPPING; EPITOPES; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SWINE; SWINE DISEASES; VIRAL VACCINES;

EID: 79955733278     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00418-10     Document Type: Article

References (57)

1. Allan, G. M., and J. A. Ellis. 2000. Porcine circoviruses: a review. J. Vet. Diagn. Invest. 12:3-14.
2. Allan, G. M., et al. 1999. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J. Comp. Pathol. 121:1-11.
3. Allan, G., et al. 2003. Reproduction of postweaning multisystemic wasting syndrome in pigs experimentally inoculated with a Swedish porcine circovirus 2 isolate. J. Vet. Diagn. Invest. 15:553-560.
4. Blanchard, P., et al. 2003. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 21:4565-4575. (Pubitemid 37315777)
5. Bolin, S. R., W. C. Stoffregen, G. P. Nayar, and A. L. Hamel. 2001. Postweaning multisystemic wasting syndrome induced after experimental inoculation of cesarean-derived, colostrum-deprived piglets with type 2 porcine circovirus. J. Vet. Diagn. Invest. 13:185-194.
6. Catanzariti, A., T. A. Soboleva, D. A. Jans, P. G. Board, and R. T. Baker. 2004. An efficient system for high-level expression and easy purification of authentic recombinant proteins. Protein Sci. 13:1331-1339. (Pubitemid 38526098)
7. Chae, C. 2005. A review of porcine circovirus 2-associated syndromes and diseases. Vet. J. 169:326-336. (Pubitemid 40542908)
8. Chae, C. 2004. Postweaning multisystemic wasting syndrome: a review of aetiology, diagnosis and pathology. Vet. J. 168:41-49. (Pubitemid 38684203)
9. Chaiyakul, M., K. Hsu, R. Dardari, F. Marshall, and M. Czub. 2010. Cytotoxicity of ORF3 proteins from a nonpathogenic and a pathogenic porcine circovirus. J. Virol. 84:11440-11447.
10. Cheung, A. K., and S. R. Bolin. 2002. Kinetics of porcine circovirus type 2 replication. Arch. Virol. 147:43-58.
11. Cheung, A. K. 2003. Comparative analysis of the transcriptional patterns of pathogenic and nonpathogenic porcine circoviruses. Virology 310:41-49. (Pubitemid 38352580)
12. Cheung, A. K. 2003. Transcriptional analysis of porcine circovirus type 2. Virology 305:168-180. (Pubitemid 36062821)
13. Darwich, L., J. Segalés, and E. Mateu. 2004. Pathogenesis of postweaning multisystemic wasting syndrome caused by porcine circovirus 2: an immune riddle. Arch. Virol. 149:857-874.
14. Dorr, P. M., G. W. Almond, S. R. Wayne, and W. A. Gebreyes. 2007. Epidemiologic assessment of porcine circovirus type 2 coinfection with other pathogens in swine. J. Am. Vet. Med. Assoc. 230:244-250.
15. Finney, D. J. 1964. The Spearman-Karber method, p. 524-530. In D. J. Finney (ed.), Statistical method in biological assay, 2nd ed. Charles Griffin, London, United Kingdom.
16. Fort, M., et al. 2008. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 26:1063-1071.
17. Fort, M., A. Olvera, M. Sibila, J. Segalés, and E. Mateu. 2007. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs. Vet. Microbiol. 125:244-255.
18. Heath, L., A. Williamson, and E. P. Rybicki. 2006. The capsid protein of beak and feather disease virus binds to the viral DNA and is responsible for transporting the replication-associated protein into the nucleus. J. Virol. 80:7219-7225.
19. Hesse, R., M. Kerrigan, and R. R. R. Rowland. 2008. Evidence for recombination between PCV2a and PCV2b in the field. Virus Res. 132:201-207.
20. Horlen, K. P., et al. 2008. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J. Am. Vet. Med. Assoc. 232:906-912.
21. Horlen, K. P., et al. 2007. A cluster of farms experiencing severe porcine circovirus associated disease: clinical features and association with the PCV2b genotype. J. Swine Health Prod. 15:270-278. (Pubitemid 47441363)
22. Juhan, N. M., T. LeRoith, T. Opriessnig, and X. J. Meng. 2010. The open reading frame 3 (ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus infection but evidence of reduced pathogenicity is limited in pigs infected by an ORF3-null PCV2 mutant. Virus Res. 147:60-66.
23. Karuppannan, A. K., et al. 2009. Attenuation of porcine circovirus 2 in SPF piglets by abrogation of ORF3 function. Virology 383:338-347.
24. Krakowka, S., et al. 2001. Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV-2). Vet. Pathol. 38:31-42. (Pubitemid 33621670)
25. Krakowka, S., et al. 2000. Viral wasting syndrome of swine: experimental reproduction of postweaning multisystemic wasting syndrome in gnotobiotic swine by coinfection with porcine circovirus 2 and porcine parvovirus. Vet. Pathol. 37:254-263.
26. Krakowka, S., et al. 2008. Evaluation of induction of porcine dermatitis and nephropathy syndrome in gnotobiotic pigs with negative results for porcine circovirus type 2. Am. J. Vet. Res. 69:1615-1622.
27. Lekcharoensuk, P., et al. 2004. Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. J. Virol. 78:8135-8145. (Pubitemid 38944298)
28. Lin, G., and P. L. Nara. 2007. Designing immunogens to elicit broadly neutralizing antibodies to the HIV-1 envelope glycoprotein. Curr. HIV Res. 5:514-541.
29. Liu, J., I. Chen, and J. Kwang. 2005. Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J. Virol. 79:8262-8274. (Pubitemid 40853530)
30. Liu, Q., S. K. Tikoo, and L. A. Babiuk. 2001. Nuclear localization of the ORF2 protein encoded by porcine circovirus type 2. Virology 285:91-99.
31. Liu, Q., P. Willson, S. Attoh-Poku, and L. A. Babiuk. 2001. Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein. Protein Expr. Purif. 21:115-120.
32. Lyoo, K., et al. 4 August 2010. Comparative efficacy of three commercial PCV2 vaccines in conventionally reared pigs. Vet. J. [Epub ahead of print.] doi:10.1016/j.tvjl.2010.06.015.
33. Ma, C., et al. 2007. Evidence for recombination in natural populations of porcine circovirus type 2 in Hong Kong and mainland China. J. Gen. Virol. 88:1733-1737.
34. Mahé, D., et al. 2000. Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. J. Gen. Virol. 81:1815-1824.
35. Mankertz, A., and B. Hillenbrand. 2001. Replication of porcine circovirus type 1 requires two proteins encoded by the viral rep gene. Virology 279:429-438. (Pubitemid 34161107)
36. Meerts, P., et al. 2006. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet. Res. 2:6.
37. Misinzo, G., P. L. Delputte, P. Meerts, D. J. Lefebvre, and H. J. Nauwynck. 2006. Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells. J. Virol. 80:3487-3494.
38. Nakai, K., and M. Kanehisa. 1992. A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics 14:897-911. (Pubitemid 23053027)
39. Nawagitgul, P., et al. 2000. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J. Gen. Virol. 81:2281-2287.
40. Olvera, A., M. Cortey, and J. Segalés. 2007. Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality. Virology 357:175-185. (Pubitemid 44834355)
41. Opriessnig, T., et al. 2006. Evidence of breed-dependent differences in susceptibility to porcine circovirus type-2-associated disease and lesions. Vet. Pathol. 43:281-293.
42. Opriessnig, T., N. E. McKeown, E. Zhou, X. Meng, and P. G. Halbur. 2006. Genetic and experimental comparison of porcine circovirus type 2 (PCV2) isolates from cases with and without PCV2-associated lesions provides evidence for differences in virulence. J. Gen. Virol. 87:2923-2932.
43. Opriessnig, T., A. R. Patterson, D. M. Madson, N. Pal, and P. G. Halbur. 2009. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 27:1002-1007.
44. Opriessnig, T., et al. 2004. Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. Vet. Pathol. 41:624-640.
45. Opriessnig, T., S. Yu, and E. L. Thacker. 2004. Derivation of porcine circovirus type 2-negative pigs from positive breeding herds. J. Swine Health Prod. 12:186-191.
46. Opriessnig, T., X. Meng, and P. G. Halbur. 2007. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J. Vet. Diagn. Invest. 19:591-615.
47. Ostrowski, M., et al. 2002. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J. Virol. 76:4241-4250. (Pubitemid 34309559)
48. Reed, J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
49. Segalés, J., et al. 2008. PCV-2 genotype definition and nomenclature. Vet. Rec. 162:867-868.
50. Segalés, J., G. M. Allan, and M. Domingo. 2005. Porcine circovirus diseases. Anim. Health Res. Rev. 6:119-142.
51. Shang, S., et al. 2009. Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2. Mol. Immunol. 46:327-334.
52. Shen, H. G., et al. 2010. Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV). Vaccine 28:5960-5966.
53. Sorden, S. D. 2000. Update on porcine circovirus and postweaning multisystemic wasting syndrom (PMWS). Swine Health Prod. 8:133-138.
54. Thomson, J. R., R. J. Higgins, W. J. Smith, and S. H. Done. 2002. Porcine dermatitis and nephropathy syndrome. Clinical and pathological features of cases in the United Kingdom (1993-1998). J. Vet. Med. A Physiol. Pathol. Clin. Med. 49:430-437.
55. Trundova, M., and V. Celer. 2007. Expression of porcine circovirus 2 ORF2 gene requires codon optimized E. coli cells. Virus Genes 34:199-204. (Pubitemid 46411973)
56. Truong, C., et al. 2001. Identification of an immunorelevant ORF2 epitope from porcine circovirus type 2 as a serological marker for experimental and natural infection. Arch. Virol. 146:1197-1211.
57. Wellenberg, G. J., N. Stockhofe-Zurwieden, M. F. de Jong, W. J. A. Boersma, and A. R. W. Elbers. 2004. Excessive porcine circovirus type 2 antibody titres may trigger the development of porcine dermatitis and nephropathy syndrome: a case-control study. Vet. Microbiol. 99:203-214.